Randomized trial compares valved holding chambers for albuterol inhalation therapy ...

Evaluation of a new pediatric asthma pilot program published in the Journal of Asthma by digital medication adherence program Emocha Health and nonprofit community health system LifeBridge Health ...

Inhaled corticosteroid (ICS) therapy was not associated with increased fracture risk in pediatric asthma patients, according ...

For many children, asthma can be a constant specter, with attacks at the most inconvenient and terrifying times. New research has now found that one inhaler containing two drugs can cut the risk of ...

BOSTON – Families have been left scrambling in recent months after a lifesaving asthma inhaler was taken off the market at the beginning of the year. Flovent HFA and Flovent Diskus, treatments that ...

Editor's note: Dr. Edith Bracho-Sanchez is a primary care pediatrician, director of pediatric telemedicine and assistant professor of pediatrics at Columbia University Irving Medical Center. Flovent, ...

MannKind (NASDAQ:MNKD) executives highlighted accelerating revenue growth, pipeline priorities, and commercialization plans during a discussion at Oppenheimer’s 36th Annual Healthcare Life Sciences ...

New research from National Jewish Health suggests that long-acting beta-agonists (LABAs), commonly used in combination asthma ...

A popular corticosteroid inhaler used to treat asthma and other conditions is being discontinued, and despite generic versions now available, health experts are warning patients to plan ahead for ...

MannKind Corporation recently enrolled the first pediatric patient in its INHALE-1ST trial and previously had an FDA supplemental Biologics License Application for Afrezza inhaled insulin in children ...